Archive - October 2018
NICE says no to AZ and Vifor’s rival hyperkalaemia drugs
US ‘unicorn’ Samumed on track with lead arthritis drug
Diabetes causing 500 premature deaths a week
Half of all kidney cancer patients initially misdiagnosed
Why Are Superstitious Beliefs So Common?
How To Deal With Sugar Cravings
FDA Approves Keytruda (pembrolizumab) in Combination with Carboplatin and Either Paclitaxel or Nab-Paclitaxel for the First-Line Treatment of Patients with Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
FDA Approves Invokana (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease